These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25613741)

  • 1. Polymorphism of the E-cadherin gene CDH1 is associated with susceptibility to vitiligo.
    Tarlé RG; Silva de Castro CC; do Nascimento LM; Mira MT
    Exp Dermatol; 2015 Apr; 24(4):300-2. PubMed ID: 25613741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDH1 and DDR1 common variants confer risk to vitiligo and autoimmune comorbidities.
    Almasi-Nasrabadi M; Amoli MM; Robati RM; Rajabi F; Ghalamkarpour F; Gauthier Y
    Gene; 2019 Jun; 700():17-22. PubMed ID: 30890477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants of the DDR1 gene are associated with vitiligo in two independent Brazilian population samples.
    Silva de Castro CC; do Nascimento LM; Walker G; Werneck RI; Nogoceke E; Mira MT
    J Invest Dermatol; 2010 Jul; 130(7):1813-8. PubMed ID: 20182441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin.
    Ricard AS; Pain C; Daubos A; Ezzedine K; Lamrissi-Garcia I; Bibeyran A; Guyonnet-Dupérat V; Taieb A; Cario-André M
    Exp Dermatol; 2012 Jun; 21(6):411-6. PubMed ID: 22507556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discoidin domain receptor-1 as a player in impairment of melanocytes adhesion process in vitiligo.
    Elgarhy LH; Abdullatif A; Abdelazim R; El-Desouky KI
    G Ital Dermatol Venereol; 2016 Oct; 151(5):473-9. PubMed ID: 26091274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility.
    Laddha NC; Dwivedi M; Mansuri MS; Singh M; Patel HH; Agarwal N; Shah AM; Begum R
    PLoS One; 2014; 9(9):e107020. PubMed ID: 25221996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between polymorphisms of discoidin domain receptor tyrosine kinase 1 (DDR1) and non-segmental vitiligo in the Korean population.
    Kim HJ; Uhm YK; Yun JY; Im SH; Yim SV; Chung JH; Shin MK; Lee MH
    Eur J Dermatol; 2010; 20(2):231-2. PubMed ID: 20007060
    [No Abstract]   [Full Text] [Related]  

  • 8. New insights into immune mechanisms of vitiligo.
    Boniface K; Taïeb A; Seneschal J
    G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced immunohistochemical expression of CCN3 in vitiligo.
    Faria AR; Jung JE; Silva de Catro CC; de Noronha L
    Indian J Dermatol Venereol Leprol; 2018; 84(5):558-562. PubMed ID: 29998862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of discoidin domain receptor 1 and E-cadherin in epidermis affects melanocyte behavior in rhododendrol-induced leukoderma mouse model.
    Abe Y; Hozumi Y; Okamura K; Suzuki T
    J Dermatol; 2020 Nov; 47(11):1330-1334. PubMed ID: 32770866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of e-cadherin gene CDH1 polymorphism -160 C/A with susceptibility to develop vitiligo.
    Kubelis-López DE; Zapata-Salazar NA; Salinas-Santander MA; Sánchez-Domínguez CN; Morlett-Chávez JA; Ocampo-Candiani J
    An Bras Dermatol; 2023; 98(3):376-378. PubMed ID: 36754648
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitiligo--part 1.
    Tarlé RG; Nascimento LM; Mira MT; Castro CC
    An Bras Dermatol; 2014; 89(3):461-70. PubMed ID: 24937821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.
    Fukunaga-Kalabis M; Martinez G; Liu ZJ; Kalabis J; Mrass P; Weninger W; Firth SM; Planque N; Perbal B; Herlyn M
    J Cell Biol; 2006 Nov; 175(4):563-9. PubMed ID: 17101694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?
    Gauthier Y; Cario Andre M; Taïeb A
    Pigment Cell Res; 2003 Aug; 16(4):322-32. PubMed ID: 12859615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    Pigment Cell Res; 2007 Aug; 20(4):271-8. PubMed ID: 17630960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.
    Blomhoff A; Kemp EH; Gawkrodger DJ; Weetman AP; Husebye ES; Akselsen HE; Lie BA; Undlien DE
    Pigment Cell Res; 2005 Feb; 18(1):55-8. PubMed ID: 15649153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetics of generalized vitiligo.
    Spritz RA
    Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-9 regulates melanocytes adhesion and migration during vitiligo repigmentation induced by UVB treatment.
    Su M; Yi H; He X; Luo L; Jiang S; Shi Y
    Exp Cell Res; 2019 Nov; 384(1):111615. PubMed ID: 31499059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
    Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
    J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.